Percheron Therapeutics (ASX:PER) Interest Expense (Positive)


What is Percheron Therapeutics Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


Percheron Therapeutics Business Description

Other Exchanges PERCF:USAAWY0:Germany
Address 35 Collins Street, Level 30, Collins Place, Melbourne, VIC, AUS, 3000
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.